The $900bn fiscal relief deal agreed by Congress won’t represent as big a fiscal expansion as the headline figures suggest as it appears to mostly involve recycling the unused funding from previous stimulus deals this year. Nevertheless, it provides another reason to expect GDP growth to rebound markedly next year as vaccines are rolled out.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services